Rational Combination of Parvovirus H1 With CTLA-4 and PD-1 Checkpoint Inhibitors Dampens the Tumor Induced Immune Silencing

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00425
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

The Safety and Tolerability of Combined Immune Checkpoint Inhibitors (Anti-Pd-1/Pd-L1 Plus Anti-Ctla-4): A Systematic Review and Meta-Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

The Efficacy and Safety of Combination of PD-1 and CTLA-4 Inhibitors: A Meta-Analysis

Experimental Hematology and Oncology
Cancer ResearchOncologyHematology
2019English

Survival Outcomes Following Combination Radiotherapy and Immune Checkpoint Inhibitors

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

4) Immune-Related Adverse Events in Endocrine Organs Induced by Immune Checkpoint Inhibitors

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
2019English

Copanlisib in Combination With Anti-Pd-1 Induces Regression in Animal Tumor Models Insensitive or Resistant to the Monotherapies of Pi3k and Checkpoint Inhibitors

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Breast Care
SurgeryOncology
2016English

PD-1 Checkpoint Blockade in Combination With an mTOR Inhibitor Restrains Hepatocellular Carcinoma Growth Induced by Hepatoma Cell-Intrinsic PD-1

Hepatology
MedicineHepatology
2017English

Infectious Complications Associated With the Use of Immune Checkpoint Inhibitors in Oncology: Reactivation of Tuberculosis After Anti PD-1 Treatment

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2018English

Immune Checkpoint Inhibitors and irAEs

Trends in Immunotherapy
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy